UnknownPHASE2, PHASE3NCT00003643
Combination Chemotherapy in Treating Men With Germ Cell Cancer
Studying Extragonadal germ cell tumor
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Principal Investigator
- Ronald De Wit, MD, PhD, MD PhDDaniel Den Hoed Cancer Center at Erasmus Medical Center
- Intervention
- bleomycin sulfate(biological)
- Enrollment
- 498 enrolled
- Eligibility
- 16-50 years · MALE
- Timeline
- 1998
Study locations (30)
- Ludwig Boltzmann Institute for Applied Cancer Research at Kaiser Franz Josef Hospital, Vienna, Austria
- Institut Jules Bordet, Brussels, Belgium
- Universitair Ziekenhuis Antwerpen, Edegem, Belgium
- U.Z. Gasthuisberg, Leuven, Belgium
- Aarhus Universitetshospital - Aarhus Sygehus, Aarhus, Denmark
- Rigshospitalet - Copenhagen University Hospital, Copenhagen, Denmark
- Centre Regional Francois Baclesse, Caen, France
- Institut Claudius Regaud, Toulouse, France
- Institut Gustave Roussy, Villejuif, France
- Charite - Universitaetsmedizin Berlin - Campus Benjamin Franklin, Berlin, Germany
- Universitaetsklinikum Bonn, Bonn, Germany
- St. Johannes Hospital - Medical Klinik II, Duisburg, Germany
- Universitaetsklinikum Essen, Essen, Germany
- Klinik Fuer Innere Medizin, Hematology/Oncology, Ernst Moritz Armdt Universitaet, Greifswald, Germany
- Allgemeines Krankenhaus Hagen, Hagen, Germany
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00003643 on ClinicalTrials.govOther trials for Extragonadal germ cell tumor
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT06418789High-dose Chemotherapy as Second-line Drug Therapy for Relapsed Germ Cell TumorsN.N. Petrov National Medical Research Center of Oncology
- RECRUITINGPHASE3NCT03067181Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell TumorsChildren's Oncology Group
- ACTIVE NOT RECRUITINGPHASE3NCT02375204Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients with Relapsed or Refractory Germ Cell TumorsAlliance for Clinical Trials in Oncology